2 min read
AGC Biologics
2 min read
AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®
December 11, 2024 at 9:00 AM
2 min read
AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer
October 28, 2024 at 3:00 AM
1 min read
AGC and MEDINET Strategic Partnership to Accelerate CGT CDMO Business in Japan
September 16, 2024 at 5:04 PM
2 min read
AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
August 25, 2020 at 7:00 AM